POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24h (1.25.2021, 10:26am CET, WHO):   The United States of America 170,883    India 13,203    Brazil 62,334    Russia 21,127    The United Kingdom 33,552    France 23,522    Italy 13,331    Germany 12,257    Columbia 15,551    Argentina 8,362    Mexico 20,057    Turkey 5,856    Poland 4,566    South Africa 12,271    Iran 5,945    Ukraine 3,915    Peru 5,842    Indonesia 11,788    The Netherlands 5,487    Czechia 4,256    Canada 5,124    Romania 2,719    Chile 4,463    Portugal 15,333    Pakistan 1,594    Philippines 1,940    Austria 1,551    Serbia 1,483    Japan 4,152    Hungary 1,257    Panama 2,058    Lebanon 3,010    United Arab Emirates 3,579    Ecuador 3,060    Slovakia 1,905    Belarus 1,748    Dominican Republic 1,439    Bolivia 1,732    Tunisia 2,059    Ireland 1,905    Malaysia 3,346    Slovenia 1,541    Honduras 1,056    Nigeria 2,464    Libya 1,148    Zambia 1,259    Cameroon 1,607    Malawi 1,076    China 205    Singapore 48    New Zealand 6    Australia 5    South Korea 437   

Russian Sputnik V anti-coronavirus vaccine registered in Algeria

Christian Fernsby |
Russia’s Sputnik V anti-coronavirus vaccine has been registered in Algeria, the vaccine’s developers said on Sunday.

Article continues below



Topics: RUSSIA    ALGERIA   

"Russian Direct Investment Fund announces the first registration of Sputnik V in Africa. Ministry of Pharmaceutical Industry of Algeria registered Sputnik V on January 10th," as follows from a post on their official Twitter account.

According to the Russian Direct Investment Fund, the registration was done under the accelerated Emergency Use Authorization procedure. This procedure was also used to register this vaccine in Argentina, Bolivia, and Serbia.

The Fund said that supplies to Algeria would be possible thanks to its international partners in India, China, South Korea and other countries.


What to read next

Russia's coronavirus vaccine Sputnik V to undergo trial in India
U.S. authorizes Moderna's coronavirus vaccine for emergency use
DNA-based vaccine guards against Zika in monkey study